ResearcherYamaguchi UniversityNo recent work listed

Arata Nishimoto

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5113954107. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment. Co-author DOI 10.3748/wjg.v28.i28.3637 ↗
Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells. Co-author DOI 10.3892/or.2017.5974 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kimikazu Hamano · 1 shared paper, 2017 · strength 0.07
- Paper Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in huma… DOI 10.3892/or.2017.5974 ↗
Daichi Kawamura · 1 shared paper, 2017 · strength 0.07
- Paper Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in huma… DOI 10.3892/or.2017.5974 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.